BRIEF-AstraZeneca Says Lynparza Combo Recommended In EU For mCRPC

Reuters | Updated: 14-11-2022 12:54 IST | Created: 14-11-2022 12:50 IST
BRIEF-AstraZeneca Says Lynparza Combo Recommended In EU For mCRPC
AstraZeneca logo Image Credit: ANI

AstraZeneca PLC: * ASTRAZENECA PLC - LYNPARZA COMBO RECOMMENDED IN THE EU FOR MCRPC

* ASTRAZENECA PLC - LYNPARZA COMBO RECOMMENDED IN THE EU FOR MCRPC * ASTRAZENECA - LYNPARZA IN COMBINATION WITH ABIRATERONE RECOMMENDED FOR APPROVAL IN EU BY CHMP Source text for Eikon: Further company coverage:

TRENDING

1
UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks in Court

UN Experts Warn Children Reporting Sexual Abuse in France Still Face Risks i...

Global
2
Hormuz Shock Forces a Rethink of How the World Secures Energy

Hormuz Shock Forces a Rethink of How the World Secures Energy

Global
3
EXCLUSIVE-Anthropic leaders to control AI lab via 'Founder LLC' to promote public good over market forces

EXCLUSIVE-Anthropic leaders to control AI lab via 'Founder LLC' to promote p...

Global
4
EXCLUSIVE-Anthropic's IPO prospectus shows sweeping AI vision, surging costs

EXCLUSIVE-Anthropic's IPO prospectus shows sweeping AI vision, surging costs

Global

PERSPECTIVES AND INSIGHTS

The Double-Edged Network: How Global Trade Shares Risk and Spreads Contagion

AI, ESG and Trust Are Becoming Interdependent Pillars of Digital Finance

Organic Vegetable Shopping Gap: What Trust and Price Mean for Everyday Shoppers

Carbon Capture Could Cut Solar Power Waste and Battery Needs Across ASEAN

DevShots

Latest News

Connect us on

LinkedIn Quora Youtube RSS
Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.

Subscribe to our Newsletter  

STANDARDS & POLICIES

EDITIONS

OTHER LINKS

CONNECT

Devdiscourse
Disclaimer | Terms of use | Privacy Policy

© Copyright 2026